Navigation Links
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
Date:5/15/2013

sement activities and outcomes and other such estimates and results.  Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K.  Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business.  Unless otherwise noted, Amgen is providing this information as of May 15, 2013 and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the past varied and we expect similar variability in the future. We develop product candidates internally and through licensing collaborations, partnerships and joint ventures.   Product candidates that are derived from relationships may be subject to disputes between the parties or may prove to be not as effective or as safe as we may have believed at the time of e
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
2. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
3. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
4. Amgen Announces Webcast of 2013 First Quarter Financial Results
5. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
6. Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference
7. Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
8. Selexis Announces Expansion of R&D License Agreement with Amgen
9. Amgen Outlines Long-Term Strategy
10. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
11. Amgen To Webcast 2013 Business Review Meeting On February 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014  Today DePuy Synthes Companies of Johnson ... systems featuring its proprietary variable angle locking technology. ... to match patient anatomy and fracture pattern and ... systems are being introduced in conjunction with the ... the International Federation of Foot & Ankle Societies ...
(Date:9/19/2014)... VIEW, Calif. , Sept. 19, 2014 Today, ... in capital from Xiaomi Ventures, Ltd. for its first ... used to continue expanding iHealth,s global reach, accelerate growth ... resources.  As part of the investment, Xiaomi Ventures will ... the areas of cloud infrastructure and ecommerce. ...
(Date:9/19/2014)...  The board of directors of AbbVie Inc. (NYSE: ... of $0.42 per share.  The cash ... record at the close of business on Oct. 15, ... research-based biopharmaceutical company formed in 2013 following separation from ... dedicated people and unique approach to innovation to develop ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
... Cargill today announced encouraging preliminary results from its ... head of beef cattle.  Initial results are based upon ... company,s Fort Morgan, Colo., beef processing facility where vaccinated ... Addressing the food and feed safety ...
... Nov. 15, 2010 Breathe Technologies, manufacturer of devices ... has appointed Lawrence A. Mastrovich as the new President ... us a phenomenal wealth of experience and strategic guidance," ... visible and instrumental role in building value within the ...
Cached Medicine Technology:Cargill Encouraged by Preliminary Results From Beef Cattle Vaccine Trial 2Cargill Encouraged by Preliminary Results From Beef Cattle Vaccine Trial 3Breathe Technologies Appoints New CEO 2
(Date:9/21/2014)... of cancer patients who smoke, those using e-cigarettes (in ... equally or less likely to have quit smoking traditional ... , a peer-reviewed journal of the American Cancer Society, ... e-cigarettes for helping cancer patients give up smoking. , ... patients who smoke should be advised to quit. But ...
(Date:9/21/2014)... Texas (PRWEB) September 22, 2014 ... originally launched in 1997, and is used prophylactically ... and adults. Its active ingredient, budesonide, is an ... corticosteroid receptor. AstraZeneca’s Pulmicort franchise includes the Pulmicort ... than six years of age, Pulmicort Respules for ...
(Date:9/21/2014)... More than a quarter of house fires are started ... two ways. The first type of dryer fire occurs when ... of dryer fire occurs when lint builds up in the dryer ... to malfunctioning electrical systems so if it doesn’t appear to be ... are some ways that you can prevent dryer fires. , Clean ...
(Date:9/21/2014)... 21, 2014 Burnaby Physiotherapists at Absolute ... clients in order to help them with preventative care. ... the clinic that will help clients understand their problem ... take active participation in the healing process. With higher ... will be able to facilitate the therapy that is ...
(Date:9/21/2014)... 21, 2014 Waldorf Risk Solutions, ... Portal designed for Diocesan risks. The portal features ... support effective risk management and loss control client ... coinciding with Waldorf’s exhibition at the Diocesan Fiscal ... applications were developed in collaboration with three Risk ...
Breaking Medicine News(10 mins):Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2Health News:Pulmicort Asthma Market (Epidemiology, Etiology, Symptoms, Diagnosis, Pathology) Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Pulmicort Asthma Market (Epidemiology, Etiology, Symptoms, Diagnosis, Pathology) Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Pulmicort Asthma Market (Epidemiology, Etiology, Symptoms, Diagnosis, Pathology) Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3Health News:Burnaby Physiotherapists Now Provide Educational Information for Preventative Care 2Health News:Waldorf Risk Solutions Releases New Risk Management Portal 2
... , , CHICAGO, July 14 ... people of Chicago, SAVE THE PATIENT, a not-for-profit patient-focused organization, ... Chicago Access Network Television (CAN-TV) airing Monday, July 20, 2009 ... , Monday,s program will feature a ...
... , , , ... leading developer of video analytics-enabled products, announced today that ... Cernium,s server-based enterprise video analytics software solution. Perceptrak will ... the Baltimore, Maryland medical center campus. , ...
... , , OAKLAND, Calif., July 14 ... Health Manager, Kaiser Permanente,s personal health record, are overwhelmingly satisfied with ... from the recent Kaiser Permanente survey examining Web site usage and ... Congress, 5th Annual Leadership Summit on Medicare in Washington, D.C. , ...
... prevent injuries, experts say , TUESDAY, July 14 (HealthDay News) ... and your mental health. , But running can be tough ... shin splints, stress fractures, pulled muscles, ankle sprains, plantar fasciitis ... back. , To prevent injuries, make sure you take precautions, ...
... better screening: study , TUESDAY, July 14 (HealthDay News) ... cancers noted in the United States since 1980, and scientists ... A new study finds that thyroid tumors of all sizes ... more aggressive screening would be expected to detect. , ...
... , , SAN DIEGO, ... today announced that OraVerse(R), the company,s premier dental pharmaceutical product, has ... of its Top 100 Products for 2009. The full results ... , , OraVerse is the first ...
Cached Medicine News:Health News:Women's Health - An Intimate Discussion 2Health News:Johns Hopkins Medical Institutions Deploys Perceptrak(R) by Cernium 2Health News:Kaiser Permanente Survey Shows Seniors Embrace Internet to Manage Their Health 2Health News:Kaiser Permanente Survey Shows Seniors Embrace Internet to Manage Their Health 3Health News:Get the Most Out of Your Run 2Health News:Get the Most Out of Your Run 3Health News:Increase in Thyroid Cancer Puzzles Experts 2Health News:OraVerse (R) Selected by Dentistry Today Magazine as One of the Top 100 Products of 2009 2Health News:OraVerse (R) Selected by Dentistry Today Magazine as One of the Top 100 Products of 2009 3
Our Osteomark® ELISA kits provide a quantitative measurement of cross-linked N-telopeptides of type I collagen (NTx) as an indicator of bone resorption, with higher levels in serum or urine sampl...
... that quantitatively measure two important cardiac risk ... serum or plasma homocysteine level is increasingly ... factor for cardiovascular disease. And numerous studies ... levels of Lp(a) with increased risk of ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
Anti-Skin Antibody (ASA) Test Kit: Pemphigus and Bullous Pemphigoid...
Medicine Products: